Evidence of occult HCV genotypes in haemophilic individuals with unapparent HCV mixed infections

Haemophilia

Volumn 14, Issue 4, 2008, Pages 816-822

  Parodi, C ^a   Culasso, A ^a,c   Aloisi, N ^a   Garcia G ^c   Baston M ^a   Corti, M ^b   Bianco, R P ^a,b   Campos, R ^c   Ares, B R ^a   Baré, Patricia ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

^b Fundación Argentina de la Haemofilia   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

HCV genotyping; HIV HCV co infection; Mixed HCV infection; Occult genotype; PBMC culture; PBMC reservoir

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; ARTICLE; BLOOD ANALYSIS; CELL CULTURE; CONTROLLED STUDY; GENOME ANALYSIS; GENOTYPE; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SUPERNATANT; VIRUS DETECTION; VIRUS STRAIN;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; GENOTYPE; HEMOPHILIA A; HEMOPHILIA B; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; INFANT; MALE; MIDDLE AGED; RNA, VIRAL; YOUNG ADULT;

EID: 47749147624     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01773.x     Document Type: Article

References (32)

1. Zeuzem S, Hultcrantz R, Bourlière M et al. Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3. J. Hepatol 2004; 40: 993-9.
2. Hayashi N, Takehara T. Antiviral therapy for chronic hepatitis C: Past, present, and future. J. Gastroenterol 2006; 41: 17-27.
3. Eyster ME, Sherman KE, Goedert JJ, Katsoulidou A, Hatzakis A. Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia. The Multicenter Hemophilia Cohort Study. J Infect Dis 1999; 179: 1062-9.
4. Blackard JT, Sherman KE. Hepatitis C virus coinfection and superinfection. J. Infect Dis 2007; 195: 519-24.
5. Schröter M, Heinz-Hubert F, Zöllner B, Schäfer P, Laufs R. Multiple infections with different HCV genotypes: Prevalence and clinical impact. J. Clin Virol 2003; 27: 200-4.
6. Picchio GR, Nakatsuno M, Boggiano C et al. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection. J. Med Virol 1997; 52: 219-25.
7. Hnatyszyn HJ. Chronic hepatitis C and genotyping: The clinical significance of determining HCV genotypes. Antivir Ther 2005; 10: 1-11.
8. Hu YW, Balaskas E, Furione M et al. Comparison and application of a novel genotyping method, semiautomated primer-specific and mispair extension analysis, and four other genotyping assays for detection of hepatitis C virus mixed-genotype infections. J. Clin Microbiol 2000; 38: 2807-13.
9. Buckton AJ, Ngui SL, Arnold C et al. Multitypic hepatitis C virus infection identified by real-time nucleotide sequencing of minority genotypes. J. Clin Microbiol 2006; 44: 2779-84.
10. Preston FE, Jarvis LM, Makris M et al. Heterogeneity of hepatitis C virus genotypes in hemophilia: Relationship with chronic liver disease. Blood 1995; 85: 1259-62.
11. Tuveri R, Rothschild C, Pol S et al. Hepatitis C virus genotypes in French haemophiliacs: Kinetics and reappraisal of mixed infections. J. Med Virol 1997; 51: 36-41.
12. Sheng L, Willems M, Peerlinck K, Vermylen J, Yap SH. Hepatitis C virus genotypes in Belgian hemophiliacs. J. Med Virol 1995; 45: 211-4.
13. Toyoda H, Fukuda Y, Hayakawa T et al. Presence of multiple genotype-specific antibodies in patients with persistent infection with hepatitis C virus (HCV) of a single genotype: Evidence for transient or occult superinfection with HCV of different genotypes. Am J Gastroenterol 1999; 94: 2230-6.
14. Viazov S, Widell A, Nordenfelt E. Mixed infection with two types of hepatitis C virus is probably a rare event. Infection 2000; 28: 21-5.
15. Isobe K, Imoto M, Fukuda Y et al. Hepatitis C virus infection and genotypes in Japanese hemophiliacs. Liver 1995; 15: 131-4.
16. Franchini M, Rossetti G, Tagliaferri A et al. The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders. Blood 2001; 98: 1836-41.
17. Radkowski M, Gallegos-Orozco JF, Jablonska J et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005; 41: 106-14.
18. Pham TN, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J. Virol 2004; 78: 5867-74.
19. Roque-Afonso AM, Ducoulombier D, Di Liberto G et al. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J. Virol 2005; 79: 6349-57.
20. Blackard JT, Hiasa Y, Smeaton L et al. Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection. J. Infect Dis 2007; 195: 1765-73.
21. BaréP, Massud I, Parodi C et al. Continuous release of hepatitis C virus (HCV) by peripheral blood mononuclear cells and B-lymphoblastoid cell-line cultures derived from HCV-infected patients. J. Gen Virol 2005; 86: 1717-27.
22. Ruibal-Ares B, Belmonte L, Baré P et al. Immortalized Epstein-Barr virus-positive B-cell lines obtained by prolonged culture of peripheral blood mononuclear cells from human immunodeficiency virus type 1-positive patients. J. Hum Virol 2001; 4: 200-13.
23. Davidson F, Simmonds P, Ferguson JC et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J. Gen Virol 1995; 76: 1197-204.
24. Baré P, Massud I, Belmonte L et al. HCV recovery from peripheral blood mononuclear cell culture supernatants derived from HCV-HIV co-infected haemophilic patients with undetectable HCV viraemia. Haemophilia 2003; 9: 598-604.
25. Gault E, Soussan P, Morice Y et al. Evaluation of a new serotyping assay for detection of anti-hepatitis C virus type-specific antibodies in serum samples. J. Clin Microbiol 2003; 41: 2084-7.
26. Bouchardeau F, Cantaloube JF, Chevaliez S et al. Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay. J. Clin Microbiol 2007; 45: 1140-5.
27. Bowden S, McCaw R, White PA, Crofts N, Aitken CK. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. J. Viral Hepat 2005; 12: 322-4.
28. McHutchison JG, Fried MW. Current therapy for hepatitis C: Pegylated interferon and ribavirin. Clin Liver Dis 2003; 7: 149-61.
29. Lauer GM, Nguyen TN, Day CL et al. Human immunodeficiency virus type 1-hepatitis C virus coinfection: Intraindividual comparison of cellular immune responses against two persistent viruses. J. Virol 2002; 76: 2817-26.
30. Tural C, Fuster D, Tor J et al. Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients. J. Viral Hepat 2003; 10: 118-25.
31. Martinez-Sierra C, Arizcorreta A, Díaz F et al. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 2003; 36: 491-8.
32. Qurishi N, Kreuzberg C, Lüchters G et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 2003; 362: 1708-13.